Ifp Advisors, Inc Otonomy, Inc. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$1.22 - $2.2 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$2.06 - $2.67 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	SELL	$2.49 - $6.23 $62 - $155	-25 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$3.16 - $4.36 $79 - $109	25 New	25 $0

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.